[Sulprostone in the treatment of uterine inertia. Report of 60 cases].
The serious haemorrhages of the delivery still one of the first causes of maternal mortality. We report an analytical study over a period of 18 months and gathering 60 cases of haemorrhage of the delivery by uterine inertia having imposed the recourse to the sulprostone. The average age of the patients was 31 years, the average parity wasv1.9, the rate of childbirth per Caesarean was 65%. The uterine surdistension was the principal etiology of the uterine inertia. The average time of administration of the sulprostone was 10 mn. No complication related to the product was noted. The effectiveness of the treatment was observed in 93.3% of the cases, with 4 cases of failure.
Mathlouthi
Nabil
N
Service A de gynécologie Obstétrique, centre de maternité et de néonatalogie de Tunis.
Khemiri
Béchir
B
Chennoufi
Mohamed Badis
MB
Elhusseini
Ali
A
Ellouze
Hanene
H
Bouchnak
Mourad
M
Hendaoui
Mohamed Salah
MS
Maghrebi
Hayene
H
Sfar
Ezzeddine
E
Chelli
Hela
H
D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011247:Pregnancy; D014593:Uterine Inertia / Q000188:drug therapy*
D000020:Abortifacient Agents, Nonsteroidal; C016767:sulprostone; D015232:Dinoprostone